Photo via Mother Jones

It Just Got Harder to Sue Over Glyphosate

Read the original at Mother Jones ↗
Cite

Hurwitz, S. (2026, November 21). It Just Got Harder to Sue Over Glyphosate. Mother Jones. https://www.motherjones.com/politics/2026/11/it-just-got-harder-to-sue-over-glyphosate/

Dated from the outlet's own feed. Check the original for its byline.

Mother Jones · collected 2026-11-21 · by Sophie Hurwitz

Quick Summary

A Missouri judge approved Bayer’s $7.25 billion settlement to resolve class action lawsuits claiming Roundup causes cancer, closing courthouse doors to future claims. The settlement, which may provide individual plaintiffs with between $10,000 and $100,000, comes after Bayer’s acquisition of Monsanto in 2018, inheriting 65,000 lawsuits over the past decade. Despite criticism of Monsanto’s influence on research, Bayer has won several court cases and shaped public opinion regarding glyphosate’s safety.
Written by AI on 2026-11-21, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

On November 20, 2026, Missouri Judge Timothy Boyer approved a $7.25 billion nationwide settlement over claims that Bayer's weedkiller Roundup caused non-Hodgkin lymphoma. The settlement applies to both current and future plaintiffs diagnosed with non-Hodgkin lymphoma after being exposed to Roundup. Payments will be made over a 20-year period, with individual payouts ranging from $10,000 to $165,000, depending on factors such as age at diagnosis and severity of illness. The settlement aims to resolve approximately 65,000 claims filed in U.S. state and federal courts.

Written for “Bayer Roundup Settlement Approved” on 2026-11-21, grounded in this article and the 6 other(s) covering the same event.
Why this leaning score
The model judged this article politically coded and scored it +0.45, but 3 quote(s) could not be found in the article and the other 1 are attributed speech rather than the article's own narration, so the score is not published.
Written under an earlier scoring contract, which gave a paragraph rather than checkable quotes. Re-analysing this article replaces it.
Leaning score withheld for article 170284: no verified evidence · logged 2026-11-21

How they differ

3 outlets covered “Bayer Roundup Settlement Approved”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

Mother JonesThis outlet21 Nov

A Missouri judge approved Bayer’s $7.25 billion settlement to resolve class action lawsuits claiming Roundup causes cancer, closing courthouse doors to future claims. The settlement, which may provide individual plaintiffs with between $10,000 and $100,000, comes after Bayer’s acquisition of Monsanto in 2018, inheriting 65,000 lawsuits over the past decade. Despite criticism of Monsanto’s influence on research…

It Just Got Harder to Sue Over Glyphosate (this article)
ABC News (AU)21 Nov

Bayer has agreed to pay up to $11 billion over two decades to settle thousands of lawsuits in the United States where cancer patients claim that the company’s weed killer Roundup caused their illness. The settlement, approved by a US judge, covers both existing cases and future claims related to non-Hodgkin lymphoma. Individual payouts range from $10,000 to $165,000, depending on the severity of the illness and…

Bayer to pay $11b over claims weed killer caused cancer →
New York Post21 Nov

Bayer, the German agrochemical company, has agreed to a settlement of up to $7.25 billion over two decades to resolve thousands of lawsuits claiming its weed killer Roundup causes cancer. U.S. cancer patients who used Roundup and those who develop non-Hodgkin lymphoma in the future are eligible for payments ranging from $10,000 to $165,000. The settlement follows a Supreme Court ruling that limited state court…

Bayer to pay out more than $7B in settlement over weed killer’s link to cancer →

Compared with similar articles

This article reads unscored and hedges 19% of its claims. Each row says how that neighbour differs.
The Guardian
Hedges 5 of 16 claims Outlet record 64/100

Story

Bayer Roundup Settlement Approved
Economy/Business · 7 article(s) covering the same event. See how they differ ↑
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
16
sentences that state something as happening or true
Uncertain
19%
3 of 16 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
60/100
Mother Jones's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
7
Economy/Business
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-21 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Mother Jones · 604 article(s) · 1 correction(s) detected
Running correction rate · 1 correction(s)

Who wrote this

Sophie Hurwitz
69 article(s) here · 1 carrying a prediction
The $7.25 billion settlement may shake out to relatively small amounts of money per individual plaintiff—somewhere between $10,000 and $100,000 per person.
2026-11-21 · assertive framing · It Just Got Harder to Sue Over Glyphosate
There are so many newly-minted AI millionaires that some writers have speculated the IPO’s winners will soon strain San Francisco’s housing market, while writers in New York City have helpfully suggested philanthropic causes to which the newly rich might apply their wealth.
2026-11-21 · mixed framing · The Anthropic IPO Was a Massive Wealth Transfer
The explosion will send a plume of lead-contaminated dust across a hundred-mile swath of the Midwest.
Times Square was blanketed in advertisements for the AI company Anthropic November 19, bearing images of bright, lush landscapes and the (Claude-inflected) slogan “What we make of this moment [sic], will make this moment.”
It would be understandable to wonder whether these things are all connected as part of some grand conspiracy.
2026-11-17 · assertive framing · Trump On All Those Outages: “It’s Fine”
States will not be forced to implement new Medicaid work requirements until mid-2027, the administration announced Friday.
The National Security Agency can continue operating under the law until March 2027, but a renewal would extend that timeline.
Van Hollen, at 67, is only eight years younger than Schumer—but his backers see him as a candidate that will, as Van Hollen put it in a speech in Denver on Friday, “shake things up.”
When Coloradans voted last week to reject an amendment that would have enshrined a right to natural gas in their state constitution, they also rebuffed a legal maneuver by a dark money group to keep Colorado reliant on deceptively dirty natural gas.
Ahmed Moor, a Philadelphia foreign policy analyst and writer, is the first candidate to announce his entry into what will likely be a crowded primary field.
Also by Sophie Hurwitz
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 69 articles by Sophie Hurwitz →

Topics

Bayer German Missouri Monsanto Roundup

Subjects

Monsanto ORG · 6× Bayer ORG · 5× Christopher A. Seeger PERSON · 1× Court ORG · 1× German NORP · 1× Missouri GPE · 1× Mother Jones ORG · 1× non-Hodgkin’s lymphoma ORG · 1× the Environmental Protection Agency ORG · 1× the Supreme Court ORG · 1×

Narrative

The company has put significant resources into shaping public opinion of glyphosate: In December of 2025, another influential journal article from 2000 that found glyphosate to be safe was retracted after its editor announced the authors had not disclosed Monsanto’s role in writing the paper.
framing: assertive · carried by 1 article(s) · first seen 2026-11-21
The $7.25 billion settlement may shake out to relatively small amounts of money per individual plaintiff—somewhere between $10,000 and $100,000 per person.
2026-11-21 · Mother Jones
It Just Got Harder to Sue Over Glyphosate · assertive framing

Claims (16 extracted, 3 hedged)

A Missouri judge on Friday granted final approval to Bayer’s $7.25 billion settlement of class action lawsuits that claimed its weedkiller, Roundup, causes cancer. asserted
weedkiller → grant → cancer
The settlement, which is subject to appeal, was “designed to resolve current and future” claims, Bayer representatives wrote in a press release, and close the courthouse doors to anyone else seeking restitution over the herbicide from the $50 billion company. uncertain
representatives → design → company
“Monsanto pursued the class settlement to significantly contain the litigation, and the settlement agreement does not contain any admission of liability or wrongdoing,” they wrote. asserted
they → pursue → liability
The $7.25 billion settlement may shake out to relatively small amounts of money per individual plaintiff—somewhere between $10,000 and $100,000 per person. uncertain
settlement → shake → person
Nonetheless, Christopher A. Seeger, a court-appointed lawyer for cancer patients in the case, claimed victory. asserted
Seeger → appoint → victory
“Today’s final approval order delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice,” he said. asserted
he → deliver → justice
When Bayer bought weedkiller manufacturer Monsanto in 2018, the German company inherited approximately 65,000 lawsuits filed against Monsanto over the past decade. asserted
company → buy → decade
Most of those suits alleged that the company’s weedkiller—which contains the controversial chemical glyphosate—caused people to develop cancers like non-Hodgkin’s lymphoma. asserted
people → allege → lymphoma
Vast numbers of people say they were harmed by the company, and members of the Make America Healthy Again movement have pressured the federal government to crack down on glyphosate. asserted
America → say → glyphosate
Still, Bayer has slowly but surely won a string of court cases. asserted
Bayer → win → cases
Much of the litigation was settled through a $10 billion settlement in 2020; five months ago, the Supreme Court ruled in a landmark case that the company could not be held liable for causing a man to develop cancer. uncertain
man → settle → cancer
That ruling, notably, was based on a 2013 study that was “ghost written” by Monsanto itself, and deemed compromised by the Environmental Protection Agency. asserted
that → base → Agency
The company has put significant resources into shaping public opinion of glyphosate: In December of 2025, another influential journal article from 2000 that found glyphosate to be safe was retracted after its editor announced the authors had not disclosed Monsanto’s role in writing the paper. asserted
authors → put → paper
A recent Mother Jones investigation about glyphosate spraying in national forests found other examples of Monsanto’s hand in secretly orchestrating research papers. asserted
investigation → spray → papers
Nonetheless, Friday’s settlement means suing the company will be more difficult in the future. asserted
suing → mean → future
“The Court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” Bayer CEO Bill Anderson said in a statement. asserted
Anderson → mitigate → statement
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support